CervoMed Inc.
corporate_fare Company Profile
CervoMed Inc. (NASDAQ:CRVO) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 41 items for CRVO at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- CervoMed's Neflamapimod Selected for UK EXPERTS-ALS Clinical Trial Platform
Financial Snapshot
Fiscal year ended December 31, 2025
Revenue
$4.01M
Net Income
-$26.97M
Op. Cash Flow
-$23.45M
Operating Income
-$28.29M
Cash & Equivalents
$8.24M
Debt / Equity
0.00×
Net Margin
-6.73×
Shares Outstanding
9.25M sh
Source: 10-K · filed 2026-03-13 · accession 0001437749-26-008259
show_chartPrice Chart
Loading chart...
feed CRVO - Filings & News (Page 3)
CRVO
Feb 18, 2026, 4:25 PM EST
Price at Filing:
$4.93
Real-time Price:
$1.44
Change:
-$3.49 (-71%)
Market Cap:
$22.088M